Concepedia

Lindsay Guerrero

LG

Statistics

Publications

2

Citations

535

H-Index

2

Active since

2018

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Lindsay Guerrero is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in oncology, inflammatory lung disease, and tumor immunity.

Top concepts

Publications per year

2018–2018

2

Publications

2

Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer

Karina Kulangara, Nancy R. Zhang, Ellie Corigliano et al. · Archives of Pathology & Laboratory Medicine · 2018 · 514 citations · Full text

Investigation of PD-L1 expression and response to pembrolizumab (pembro) in gastric cancer (GC) and cervical cancer (CC) using combined positive score (CPS) and tumor proportion score (TPS).

Karina Kulangara, Lindsay Guerrero, Alex Posch et al. · Journal of Clinical Oncology · 2018 · 21 citations

, , +18

1–2 of 2